| Dr Oscar Mims, MD | |
|
106 Irving St Nw, Suite 3800n, Washington, DC 20010-2927 | |
| (202) 877-6093 | |
| Not Available |
| Full Name | Dr Oscar Mims |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 41 Years |
| Location | 106 Irving St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326019589 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | MD15669 (District Of Columbia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
In work that could lead to safe and effective techniques for gene therapy, MIT researchers have found a way to fine-tune the ability of biodegradable polymers to deliver genes.
Scientists at Sanford Burnham Prebys Medical Discovery Institute have solved the atomic structure of a unique ubiquitin ligase complex. Ubiquitin is best known for its role in protein degradation, but more recently seen as important for cell signaling, DNA repair, anti-inflammatory, and immune responses.
Johns Hopkins researchers have developed a computer simulation that helps predict under which circumstances a new short-course treatment regimen for drug-resistant tuberculosis could substantially reduce the global incidence and spread of the disease.
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was found to be effective against a specific genetic subtype of acute myeloid leukemia (AML) in a Phase Ib/II trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 7 days ago
| Entity Name | Howard University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033163597 PECOS PAC ID: 0941109565 Enrollment ID: O20040102000561 |
News Archive
In work that could lead to safe and effective techniques for gene therapy, MIT researchers have found a way to fine-tune the ability of biodegradable polymers to deliver genes.
Scientists at Sanford Burnham Prebys Medical Discovery Institute have solved the atomic structure of a unique ubiquitin ligase complex. Ubiquitin is best known for its role in protein degradation, but more recently seen as important for cell signaling, DNA repair, anti-inflammatory, and immune responses.
Johns Hopkins researchers have developed a computer simulation that helps predict under which circumstances a new short-course treatment regimen for drug-resistant tuberculosis could substantially reduce the global incidence and spread of the disease.
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was found to be effective against a specific genetic subtype of acute myeloid leukemia (AML) in a Phase Ib/II trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 7 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000415 |
News Archive
In work that could lead to safe and effective techniques for gene therapy, MIT researchers have found a way to fine-tune the ability of biodegradable polymers to deliver genes.
Scientists at Sanford Burnham Prebys Medical Discovery Institute have solved the atomic structure of a unique ubiquitin ligase complex. Ubiquitin is best known for its role in protein degradation, but more recently seen as important for cell signaling, DNA repair, anti-inflammatory, and immune responses.
Johns Hopkins researchers have developed a computer simulation that helps predict under which circumstances a new short-course treatment regimen for drug-resistant tuberculosis could substantially reduce the global incidence and spread of the disease.
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was found to be effective against a specific genetic subtype of acute myeloid leukemia (AML) in a Phase Ib/II trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Oscar Mims, MD 17741 New Hampshire Ave, Ashton, MD 20861-3631 Ph: (301) 570-4662 | Dr Oscar Mims, MD 106 Irving St Nw, Suite 3800n, Washington, DC 20010-2927 Ph: (202) 877-6093 |
News Archive
In work that could lead to safe and effective techniques for gene therapy, MIT researchers have found a way to fine-tune the ability of biodegradable polymers to deliver genes.
Scientists at Sanford Burnham Prebys Medical Discovery Institute have solved the atomic structure of a unique ubiquitin ligase complex. Ubiquitin is best known for its role in protein degradation, but more recently seen as important for cell signaling, DNA repair, anti-inflammatory, and immune responses.
Johns Hopkins researchers have developed a computer simulation that helps predict under which circumstances a new short-course treatment regimen for drug-resistant tuberculosis could substantially reduce the global incidence and spread of the disease.
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was found to be effective against a specific genetic subtype of acute myeloid leukemia (AML) in a Phase Ib/II trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 7 days ago
Dr. Steven Joseph Ralston, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2150 Pennsylvania Ave Nw, Washington, DC 20037 Phone: 202-741-2500 | |
Gloria Bowles-johnson, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-8232 | |
Mary Melody Abraham, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1145 19th St Nw, Suite 410, Washington, DC 20036 Phone: 202-331-1740 Fax: 202-296-9784 | |
Dr. Edward James Tanner Iii, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5275 Loughboro Rd Nw Bldg D, Washington, DC 20016 Phone: 202-243-5295 Fax: 202-537-4662 | |
Dr. Richard J. Beckerman, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 5215 Loughboro Rd Nw, Suite 500, Washington, DC 20016 Phone: 202-243-3500 Fax: 202-966-8441 | |
Kimberly Suzanne Moon, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2021 K St Nw, Suite 701, Washington, DC 20006 Phone: 202-296-2595 Fax: 202-296-2835 | |
Dr. Deborah Martina Smith, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1701 14th St Nw, Elizabeth Taylor Medical Center, Washington, DC 20009 Phone: 202-745-7000 Fax: 202-745-0238 |